BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29470550)

  • 1. The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.
    Rigalli JP; Reichel M; Reuter T; Tocchetti GN; Dyckhoff G; Herold-Mende C; Theile D; Weiss J
    PLoS One; 2018; 13(2):e0193242. PubMed ID: 29470550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
    Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
    Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma.
    Reuter T; Warta R; Theile D; Meid AD; Rigalli JP; Mogler C; Herpel E; Grabe N; Lahrmann B; Plinkert PK; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1141-50. PubMed ID: 26141049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
    Huang J; Ji EH; Zhao X; Cui L; Misuno K; Guo M; Huang Z; Chen X; Hu S
    J Exp Clin Cancer Res; 2019 Mar; 38(1):138. PubMed ID: 30922366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway.
    Ma C; Wang J; Fan L; Guo Y
    Exp Mol Pathol; 2017 Feb; 102(1):59-64. PubMed ID: 28062212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sprouty2 protein is downregulated in human squamous cell carcinoma of the head and neck and suppresses cell proliferation in vitro.
    Lin CL; Chiang WF; Tung CL; Hsieh JL; Hsiao JR; Huang WT; Feng LY; Chang CH; Liu SY; Tsao CJ; Feng YH
    Mol Med Rep; 2015 Jan; 11(1):547-54. PubMed ID: 25333206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT).
    Johnson DR; Li CW; Chen LY; Ghosh JC; Chen JD
    Mol Pharmacol; 2006 Jan; 69(1):99-108. PubMed ID: 16219912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMS-275183-induced gene expression patterns in head and neck carcinoma.
    Yoo GH; Tran VR; Lemonnier LA; Ezzat WH; Subramanian G; Piechocki MP; Ensley JF; Lonardo F; Kim H; Lin HS
    Am J Otolaryngol; 2007; 28(5):309-15. PubMed ID: 17826531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
    Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
    Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
    Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
    Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
    Wang H; Xue W; Jiang X
    Biomed Res Int; 2018; 2018():6142843. PubMed ID: 29862279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
    Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
    Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification.
    Leopoldino AM; Squarize CH; Garcia CB; Almeida LO; Pestana CR; Sobral LM; Uyemura SA; Tajara EH; Silvio Gutkind J; Curti C
    Oral Oncol; 2012 Nov; 48(11):1106-13. PubMed ID: 22739068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninein-like protein is overexpressed in head and neck squamous cell carcinoma and contributes to cancer growth and resistance to apoptosis.
    Yu L; Song Y; Zhang Q; Zhan Q
    Oncol Rep; 2009 Oct; 22(4):789-98. PubMed ID: 19724857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression.
    Moon SM; Kim SA; Yoon JH; Ahn SG
    J Biol Chem; 2012 Oct; 287(42):35678-35688. PubMed ID: 22896703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.